Agenus Inc. ( AGEN) - Key Metrics
AGEN Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.97 | -$0.30 | -$2.77 | -$2.78 |
| 2025Q3 | $0.95 | $2 | -$0.46 | -$0.46 |
| 2025Q2 | $0.91 | -$0.99 | -$0.72 | -$0.72 |
| 2025Q1 | $0.98 | -$1.03 | -$1.05 | -$1.05 |
AGEN Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -2.62 |
| 2025Q3 | ? | 0.48 |
| 2025Q2 | ? | -1.15 |
| 2025Q1 | ? | -0.37 |
AGEN Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | -28.37% | ? |
| 2025Q4 | -14.98% | ? |
| 2025Q3 | -12.00% | ? |
| 2025Q2 | -15.74% | ? |
| 2025Q1 | -69.35% | ? |
AGEN
Price: $2.98
52 week price:
Payout Ratio Range:
Earnings Per Share: 2.05 USD
P/E Ratio: 1.75
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 207310
Ebitda: -30.2 millionMarket Capitalization: 134.1 million